PPSG
VRTX icon

Princeton Portfolio Strategies Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Princeton Portfolio Strategies Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,930
Closed -$415K – 156
2021
Q1 		$415K Hold
1,930
– – 0.08% 129
2020
Q4 		$456K Hold
1,930
– – 0.09% 128
2020
Q3 		$525K Hold
1,930
– – 0.11% 115
2020
Q2 		$560K Hold
1,930
– – 0.13% 108
2020
Q1 		$459K Hold
1,930
– – 0.13% 106
2019
Q4 		$423K Hold
1,930
– – 0.1% 116
2019
Q3 		$327K Hold
1,930
– – 0.08% 123
2019
Q2 		$354K Hold
1,930
– – 0.09% 123
2019
Q1 		$355K Hold
1,930
– – 0.09% 128
2018
Q4 		$320K Hold
1,930
– – 0.1% 126
2018
Q3 		$372K Hold
1,930
– – 0.1% 128
2018
Q2 		$328K Hold
1,930
– – 0.1% 129
2018
Q1 		$315K Hold
1,930
– – 0.09% 130
2017
Q4 		$289K Hold
1,930
– – 0.08% 136
2017
Q3 		$293K Hold
1,930
– – 0.08% 150
2017
Q2 		$249K Sell
1,930
-200
-9% -$24.1K 0.07% 146
2017
Q1 		$233K Buy
+2,130
New +$188K 0.07% 156
2016
Q1 		– Sell
-2,150
Closed -$271K – 144
2015
Q4 		$271K Sell
2,150
-200
-9% -$24.1K 0.1% 121
2015
Q3 		$245K Hold
2,350
– – 0.1% 119
2015
Q2 		$290K Sell
2,350
-550
-19% -$69.3K 0.1% 117
2015
Q1 		$342K Hold
2,900
– – 0.13% 95
2014
Q4 		$345K Hold
2,900
– – 0.14% 98
2014
Q3 		$326K Hold
2,900
– – 0.14% 99
2014
Q2 		$275K Hold
2,900
– – 0.12% 108
2014
Q1 		$205K Sell
2,900
-500
-15% -$39.6K 0.14% 105
2013
Q4 		$253K Buy
3,400
+200
+6% +$13.9K 0.17% 103
2013
Q3 		$243K Buy
3,200
+175
+6% +$13.9K 0.18% 97
2013
Q2 		$242K Buy
+3,025
New +$223K 0.2% 94

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Princeton Portfolio Strategies Group's VRTX Position: Q2 2021 in Review

Princeton Portfolio Strategies Group sold out of Vertex Pharmaceuticals (VRTX) in Q2 2021, closing a stake of 1,930 shares — an estimated $415K sold.

Princeton Portfolio Strategies Group first reported a position in VRTX in Q2 2013 and held it in 28 quarters. The position peaked at $560K in Q2 2020. 976 funds tracked by Wall St. Rank hold VRTX as of Q2 2021.

  • Princeton Portfolio Strategies Group reported no remaining Vertex Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Princeton Portfolio Strategies Group sold 1,930 Vertex Pharmaceuticals shares in Q2 2021, an estimated $415K.
  • Princeton Portfolio Strategies Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 28 quarters.
  • Princeton Portfolio Strategies Group's Vertex Pharmaceuticals position peaked at $560K in Q2 2020.
  • 976 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2021.

Based on Princeton Portfolio Strategies Group's 13F filing for Q2 2021, filed 2 Aug 2021.